Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Neoplasms 3 Esophageal Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Cyclophosphamide 12 Specimen Handling 9 cabozantinib 8 X-Rays 8 Magnetic Resonance Spectroscopy 8 fludarabine 7 Phantoms, Imaging 7 Biopsy 7 Temozolomide 6 Gemcitabine 5 regorafenib 4 pembrolizumab 4 Vincristine 4 Nuclear Medicine Department, Hospital 4 Nivolumab 4 Methotrexate 4 Doxorubicin 4 olaparib 3 irinotecan sucrosofate 3 fludarabine phosphate 3 dinutuximab 3 Zoledronic Acid 3 Surveys and Questionnaires 3 Irinotecan 3 Ifosfamide 3 Cisplatin 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Pafolacianine × 1 year × Clear all

NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡